Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials

6 Jun 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Chronic Disease Management Strategies
Share to Down syndrome and intellectual disability research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32506291
DOI: 10.1007/s40263-020-00740-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention TrialsPMID 32506291Read ↗

Alzheimer's disease in Down syndrome: An overlooked population for prevention trialsSemantic proximity Read ↗

Dementia in Down syndrome: unique insights for Alzheimer disease researchSemantic proximity Read ↗

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discoverySemantic proximity Read ↗

Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerationsSemantic proximity Read ↗

Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatmentsSemantic proximity Read ↗

Aging with Down Syndrome—Where Are We Now and Where Are We Going?Semantic proximity Read ↗

Genetics of Down's syndrome and Alzheimer's diseaseSemantic proximity Read ↗

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodologySemantic proximity Read ↗

From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approachSemantic proximity Read ↗

Down's syndrome and Alzheimer's disease: towards secondary prevention.Semantic proximity Read ↗

Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndromeSemantic proximity Read ↗

Integrating Biomarker Outcomes into Clinical Trials for Alzheimer's Disease in Down SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.